Patients breast anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Cell Line Mammary Glands, Human HCT116 Cells Milk, Human HT29 Cells Nipples HeLa Cells Axilla

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases36

Radiation Injuries Carcinoma, Ductal, Breast Breast Diseases Neoplasms Breast Neoplasms, Male Radiation Injuries, Experimental Neoplasms, Radiation-Induced Radiation Pneumonitis Fibrocystic Breast Disease Neoplasm Metastasis Neoplasm Invasiveness Carcinoma Carcinoma, Intraductal, Noninfiltrating Breast Neoplasms Mammary Neoplasms, Experimental Adenocarcinoma Carcinoma, Lobular Colonic Neoplasms Lymphatic Metastasis Acute Radiation Syndrome Neoplasm Recurrence, Local Ovarian Neoplasms Neoplasms, Experimental Lung Neoplasms Brain Neoplasms Radiodermatitis Breast Cyst Neovascularization, Pathologic Fibroadenoma Leukemia P388 Bone Neoplasms Neoplasms, Hormone-Dependent Cell Transformation, Neoplastic Carcinoma, Squamous Cell Head and Neck Neoplasms Leukemia, Radiation-Induced

Chemicals and Drugs81

Antineoplastic Agents Doxorubicin Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Cisplatin Receptors, Estrogen Drug Carriers Receptor, erbB-2 Radiation-Sensitizing Agents Ellipticines Neoplasm Proteins Tamoxifen Etoposide P-Glycoprotein Tumor Markers, Biological Camptothecin Receptors, Progesterone Fluorouracil Paclitaxel Tumor Suppressor Protein p53 Enzyme Inhibitors DNA Topoisomerases, Type II Radiation-Protective Agents RNA, Messenger Prodrugs Plant Extracts RNA, Small Interfering DNA, Neoplasm Antineoplastic Agents, Hormonal Topoisomerase I Inhibitors Antimetabolites, Antineoplastic Proto-Oncogene Proteins c-bcl-2 Daunorubicin DNA Caspases Mitoxantrone Platinum Nanocapsules Taxoids Caspase 3 Cobalt Radioisotopes Antineoplastic Agents, Alkylating Anticarcinogenic Agents DNA-Binding Proteins Organoplatinum Compounds Vinblastine DNA Adducts Mitomycin ATP-Binding Cassette Transporters Cyclophosphamide Multidrug Resistance-Associated Proteins Antibodies, Monoclonal Drugs, Investigational Protein-Serine-Threonine Kinases Intercalating Agents Tumor Suppressor Proteins Estrogen Receptor alpha Estrogens Topoisomerase II Inhibitors Xanthones Adjuvants, Pharmaceutic Bleomycin BRCA1 Protein Methotrexate Tubulin Modulators Topoisomerase Inhibitors Razoxane Reactive Oxygen Species DNA Topoisomerases, Type I Deoxycytidine Receptor, Epidermal Growth Factor BRCA2 Protein Coordination Complexes Protein Kinase Inhibitors Epirubicin Antibodies, Monoclonal, Humanized Liposomes Angiogenesis Inhibitors Cell Cycle Proteins Poly(ADP-ribose) Polymerases Vincristine

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Injuries, Experimental Radiotherapy Mammography Drug Carriers Radiotherapy Dosage Breast Implants Radiometry Inhibitory Concentration 50 Antineoplastic Combined Chemotherapy Protocols Prognosis Breast Self-Examination Combined Modality Therapy Mastectomy Neoplasm Staging Treatment Outcome Neoplasm Transplantation Drug Design Immunohistochemistry Blotting, Western Transplantation, Heterologous Mammary Neoplasms, Experimental Risk Factors Mastectomy, Segmental Radiotherapy, Adjuvant Chemotherapy, Adjuvant Tumor Burden Molecular Targeted Therapy Ultrasonography, Mammary Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Case-Control Studies Models, Biological Drug Evaluation, Preclinical Gene Expression Profiling Neoplasms, Experimental Radiotherapy, Conformal Transfection Disease-Free Survival Nanocapsules Clinical Trials as Topic Drug Discovery Mammaplasty Retrospective Studies Dose Fractionation Follow-Up Studies Radiation Hybrid Mapping Brachytherapy Tumor Stem Cell Assay Radiotherapy, Intensity-Modulated Survival Rate Radiotherapy Planning, Computer-Assisted Sensitivity and Specificity Flow Cytometry Reproducibility of Results Risk Assessment Oligonucleotide Array Sequence Analysis Body Burden Prospective Studies Clinical Trials, Phase I as Topic Breast Implantation Cohort Studies Risk Incidence

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes54

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Drug Resistance, Neoplasm Breast Feeding Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation Cosmic Radiation Gamma Rays DNA Damage Time Factors Background Radiation Dose-Response Relationship, Drug Cell Cycle Ultraviolet Rays Drug Resistance, Multiple Inhibitory Concentration 50 Drug Synergism Molecular Structure Signal Transduction Radiation Effects Cell Division DNA Repair X-Rays Mutation Down-Regulation Transfection Genes, BRCA1 Cell Death DNA Adducts Phosphorylation Base Sequence Postmenopause Drug Resistance Structure-Activity Relationship Cell Growth Processes Cell Cycle Checkpoints Up-Regulation Sensitivity and Specificity Genes, MDR RNA Interference Gene Expression Linear Energy Transfer Premenopause Enzyme Activation G2 Phase Risk Tissue Distribution Menopause Genes, BRCA2

Disciplines and Occupations6

Radiation Oncology Drug Design Immunohistochemistry Nanomedicine Drug Discovery Radiobiology

Anthropology, Education, Sociology and Social Phenomena1

Nuclear Warfare

Technology, Industry, Agriculture5

Nanoparticles Nanomedicine Nanocapsules Milk, Human Liposomes

Information Science7

Radiotherapy, Conformal Molecular Sequence Data Base Sequence Radiotherapy, Intensity-Modulated Survival Rate Radiotherapy Planning, Computer-Assisted Incidence

Health Care29

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Radiation Effects Treatment Outcome Risk Factors Acute Radiation Syndrome Survival Analysis Case-Control Studies Disease-Free Survival Clinical Trials as Topic Retrospective Studies Radioactive Hazard Release Follow-Up Studies Survival Rate Sensitivity and Specificity Reproducibility of Results Risk Assessment Body Burden Prospective Studies Clinical Trials, Phase I as Topic Cohort Studies Risk Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Breast Antineoplastic Agents Radiation Dosage Radiation, Ionizing Radiation Injuries Cell Line, Tumor Carcinoma, Ductal, Breast Dose-Response Relationship, Radiation Radiation Tolerance Breast Diseases Radiation Drug Screening Assays, Antitumor Radiation Protection Neoplasms Radiation Monitoring Apoptosis Drug Resistance, Neoplasm Doxorubicin Breast Feeding Tumor Cells, Cultured Antineoplastic Agents, Phytogenic Radiation Oncology Antibiotics, Antineoplastic Cell Survival Mice, Nude Gene Expression Regulation, Neoplastic Cisplatin Cell Proliferation Xenograft Model Antitumor Assays Drug Delivery Systems Cosmic Radiation Gamma Rays Receptors, Estrogen Breast Neoplasms, Male Radiation Injuries, Experimental DNA Damage Radiotherapy Neoplasms, Radiation-Induced Radiation Pneumonitis Mammography Drug Carriers Receptor, erbB-2 Radiation-Sensitizing Agents Fibrocystic Breast Disease Time Factors Background Radiation Ellipticines Neoplasm Proteins Dose-Response Relationship, Drug Tamoxifen Radiotherapy Dosage MCF-7 Cells Breast Implants Cell Cycle Ultraviolet Rays Radiometry Etoposide Drug Resistance, Multiple P-Glycoprotein Tumor Markers, Biological Inhibitory Concentration 50 Antineoplastic Combined Chemotherapy Protocols Camptothecin Prognosis Receptors, Progesterone Fluorouracil Breast Self-Examination Neoplasm Metastasis Drug Synergism Paclitaxel Combined Modality Therapy Molecular Structure Signal Transduction Neoplasm Invasiveness Mastectomy Tumor Suppressor Protein p53 Radiation Effects Neoplasm Staging Treatment Outcome Neoplasm Transplantation Drug Design Cell Division Carcinoma Enzyme Inhibitors Immunohistochemistry Carcinoma, Intraductal, Noninfiltrating Breast Neoplasms DNA Topoisomerases, Type II Blotting, Western Radiation-Protective Agents DNA Repair RNA, Messenger Prodrugs Transplantation, Heterologous Mammary Neoplasms, Experimental Risk Factors Adenocarcinoma Carcinoma, Lobular Plant Extracts Mastectomy, Segmental

No FAQ available that match "patients breast anticancer drugs or radiation"